The prenatal diagnostic indicators of placenta accreta spectrum disorders

Placenta accreta spectrum (PAS) disorders refers to a heterogeneous group of anomalies distinguished by abnormal adhesion or invasion of chorionic villi through the myometrium and uterine serosa. PAS frequently results in life-threatening complications, including postpartum hemorrhage and hysterotom...

Full description

Saved in:
Bibliographic Details
Published inHeliyon Vol. 9; no. 5; p. e16241
Main Authors Wu, Xiafei, Yang, Huan, Yu, Xinyang, Zeng, Jing, Qiao, Juan, Qi, Hongbo, Xu, Hongbing
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.05.2023
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Placenta accreta spectrum (PAS) disorders refers to a heterogeneous group of anomalies distinguished by abnormal adhesion or invasion of chorionic villi through the myometrium and uterine serosa. PAS frequently results in life-threatening complications, including postpartum hemorrhage and hysterotomy. The incidence of PAS has increased recently as a result of rising cesarean section rates. Consequently, prenatal screening for PAS is essential. Despite the need to increase specificity, ultrasound is still considered a primary adjunct. Given the dangers and adverse effects of PAS, it is necessary to identify pertinent markers and validate indicators to improve prenatal diagnosis. This article summarizes the predictors regarding biomarkers, ultrasound indicators, and magnetic resonance imaging (MRI) features. In addition, we discuss the effectiveness of joint diagnosis and the most recent research on PAS. In particular, we focus on (a) posterior placental implantation and (b) accreta after in vitro fertilization-embryo transfer, both of which have low diagnostic rates. At last, we graphically display the prenatal diagnostic indicators and each diagnostic performance.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Xiafei Wu and Huan Yang should be considered joint first author.
ISSN:2405-8440
2405-8440
DOI:10.1016/j.heliyon.2023.e16241